Fresenius Medical Care
Fresenius Medical Care AG & Co. KGaA legally established in Hof an der Saale and operational headquarters in Bad Homburg vor der Höhe is the world's leading provider of dialysis products and services to about life-saving treatment of people with chronic and acute renal failure.
Fresenius Medical Care AG was formed on 5 August 1996 by converting the shelf company was founded in 1975 Sterile Pharma GmbH into a stock corporation. At that time the former Fresenius AG acquired the world's largest operator of dialysis clinics, National Medical Care in the U.S., and brought them with its own dialysis technology division in Fresenius Medical Care AG.
On April 21, 2005, Fresenius Medical Care acquired the Canadian company Haemotec, a manufacturer of concentrates for hemodialysis.
On May 4, 2005, Fresenius Medical Care announced the competitors Renal Care Group to take over for 3.5 billion U.S. dollars (48 U.S. dollars per share). The acquisition was completed on 31 March 2006 subject to conditions from the U.S. antitrust authorities.
On 30 August 2005, the Management Board and the Supervisory Board of Fresenius Medical Care AG proposed to the shareholders to convert the legal form of a stock corporation into a partnership limited by shares. After the approval of the shareholders, this was done on 10 February 2006.
On October 12, 2006, Fresenius Medical Care took over the phosphate binder business of Nabi Biopharmaceuticals and completed the acquisition on 15 November 2006 successfully.
On January 9, 2007, the Company acquired a majority stake of 51 percent of the Taiwanese dialysis service providers Jiate Excelsior and got it the leading dialysis provider in Asia.
On 29 November 2007, Fresenius Medical Care Renal Solutions, a provider of home hemodialysis for $ 190 million, of which $ 100 million will be paid upon completion of purchase.
June 30, 2010 Kraevoy Nefrologicheskiy Centr, a Russian operator was acquired by dialysis clinics.
For 485 million euros, the dialysis service business was acquired by Euro Medic on January 4, 2011. The acquisition was completed on 1 July 2011.
On 1 December 2011, Fresenius Medical Care has taken over all eight privately run clinics in Ecuador.
The acquisition of peritoneal dialysis business from Gambro was announced on 26 August 2010 and completed on December 27, 2010.
On February 29, 2012, the Company acquired the US-based holding company for Liberty Dialysis Holdings, to which the two American companies Liberty Dialysis and Renal Advantage include, for $ 1.7 billion ( 1.31 billion euros ) under certain conditions.
One of the great German production sites include the Schweinfurt in Bavaria and the plant in St. Wendel in the Saarland. In opened in 1979 Schweinfurt plant about 1200 employees manufacture dialysis machine, opened in 1974 in St. Wendel plant are manufactured by about 1700 employees dialyzers and solutions for peritoneal dialysis. The legal domicile of the Fresenius Medical Care is located since its founding in Hof an der Saale, the operational headquarters, however, in Bad Homburg. In court no employees.
As the legal successor of Grace, the parent company of National Medical Care, Fresenius Medical Care paid 115 million U.S. $ damages for asbestos-related claims and tax claims against WR Grace.
In the course of this litigation was alleged that the merger of National Medical Care and the dialysis business of Fresenius was made fraudulently to get rid of the liabilities of Grace ( Annual Report of the FMC 2004, page 71).
The Company's shares are traded since October 2, 1996 at the Frankfurt Stock Exchange since 17 October 1996 at the New York Stock Exchange and in 1999 a member of the DAX since 20 September. The largest single shareholder is the Fresenius SE & Co. KGaA, which holds 30.8 percent of the capital. The remaining shares are in free float.
The company offers (chronic and acute) and peritoneal dialysis such as hemodialysis machines, dialyzers and related disposable products and solutions to a wide range of products for hemodialysis.